Distribution and kinetics of amylin in humans.
The aim of the study was to determine the apparent volume of distribution (VTOT), total body clearance (CL), fractional clearance, and mean residence time (MRT) of the beta-cell hormone amylin. We therefore performed an intravenous injection of 50 micrograms of human synthetic amylin (amlintide) in nine healthy male subjects during suppression of endogenous amylin release by intravenous somatostatin (0.06 microgram.kg-1.min-1). The plasma levels of amylin concentrations over time were analyzed using three-exponential curves. VTOT was 173 +/- 16 ml/kg and was not different from that of insulin reported in the literature (157 ml/kg). MRT was 27.7 +/- 2.1 min and thus two times the reported value for insulin (14.1 min) and C-peptide (16.4 min). CL and fractional CL were 6.2 +/- 0.2 ml.kg-1.min-1 and 0.038 +/- 0.003 min-1, respectively. Fractional CL is therefore definitely lower than that reported for insulin (0.12-0.2 min-1) but is, however, in the range of that of C-peptide (0.05 min-1). In conclusion, clearance of amylin is similar to that reported for C-peptide and much slower than insulin, indicating that the commonly used molar insulin-to-amylin ratio does not reflect the correct relationship of the two peptides.
Clodi
M
M
Department of Medicine III, University of Vienna, Austria.
Thomaseth
K
K
Pacini
G
G
Hermann
K
K
Kautzky-Willer
A
A
Waldhüsl
W
W
Prager
R
R
Ludvik
B
B
D000328:Adult; D000682:Amyloid / Q000097:blood / Q000378:metabolism* / Q000493:pharmacokinetics; D006207:Half-Life; D006801:Humans; D058228:Islet Amyloid Polypeptide; D007700:Kinetics; D008297:Male; D008954:Models, Biological; D014018:Tissue Distribution
D000682:Amyloid; D058228:Islet Amyloid Polypeptide